Press

events

TXP Medical CEO Sonoo and our company CEO Igawa held a discussion on the topic of clinical trial digital transformation.

From left, Tomoya Osumi, Strategy Development Officer (SDO) of the Medical Data Business Division and Director of the Medical Data Lab at TXP Medical, Takateru Inoue, CEO of Buzzreach Inc., and Tomohiro Sonoo, CEO of TXP Medical

Title: What is the cutting edge of clinical trial DX and what kind of professionals are needed now?

■ Summary of the roundtable discussion

Roundtable discussion series “Map of the Future of Life Sciences: Exploring Medical Data with Industry Leaders Vol. 4”

■ Main topics of the roundtable discussion

・Why is clinical trial digital transformation progressing? ・KPI-driven operations provide room for technology adoption
・The key to success is both “wet” and “dry” processes – the power of accompanying each other to move the field
・Collaboration between pharmaceutical companies and startups drives changes in the industry structure
・Refining feasibility and operational challenges – the potential of AI and RWD
・What is the future vision for electronic medical records as a “platform for clinical research”?

Click here for the note article.

Speakers:
Takateru Inokawa (CEO of Buzzreach Inc.),
Tomohiro Sonoo (CEO of TXP Medical Inc.),
Tomoya Osumi (Strategic Promotion Officer of Medical Data Business Division, TXP Medical / Director of Medical Data Lab)

This is an open lab where pharmaceutical companies and other people involved in medical data can come together to learn from each other, think together, and engage in dialogue toward implementation. As the word “Lab” suggests, this is a place where knowledge and hypotheses can be pooled together to generate common knowledge for the improvement of medical care.

TXP Medical page

https://medical-dataservice.com/news/ZUWF0czb

PR TIMES

https://prtimes.jp/main/html/rd/p/000000136.000031630.html